Leif G Salford | OMICS International

Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Leif G Salford

Leif G. Salford is Professor and Chairman of the Department of Neurosurgery, Lund University, Sweden. He is also Director of the Rausing Laboratory for Translational Neurooncology and Coordinator of Translational Research of the Faculty of Medicine. He is former Director of the Institute of Clinical Sciences, Lund University and of the clinical departments of Neuro- and Sensory Sciences, Lund University Hospital.


He received his MD 1969 and PhD 1974 at Lund University. He was Wrightsman Scholar 1972-73, Dept. of Neurology and Neurosurgery, Cornell Medical Center, New York Hospital, N.Y. He has been Professor and Chairman, Department of Neurosurgery, Kuwait University and Dept of Neurosurgery, Göteborg University, Sweden. He has been expert in Information Society Forum, European Union, Chairman of the World Federation of Neurosurgical Societies Committee on Neuro-oncology, President of the European Association for Neuro-Oncology, President of the Scandinavian Neuro-Oncology Society 1990-97 and President of the Swedish Neurosurgical Association.

Research Interest

His major scientific work is within the field of neurosurgical oncology, where he has been active since the 70-ies and where his actual research combines immune- and gene therapy against the most malignant brain tumours, where results from experimental models are translated to the human situation. In his search for improved therapies against brain tumours, he and his group in Lund, tried to utilize electromagnetic fields to open the Blood Brain Barrier for cytotoxins – this lead to the observation that RF fields at very low SAR values have the potency to facilitate the passage of albumin through the capillaries into the brain and to damage neurons in experimental animals.

Global Speakers in the subject

Global Experts in the subject